Navigation Links
Cumberland Pharmaceuticals Reports 2012 Annual Financial Results
Date:2/28/2013

ts anticipated by the Company will be realized or that they will have the expected effects. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date hereof. The Company does not undertake any obligation to publicly revise these statements to reflect events after the date hereof.CUMBERLAND PHARMACEUTICALS INC. AND SUBSIDIARIES
Condensed Consolidated Balance Sheets

(unaudited)
December 31, 2012 and 201120122011ASSETSCurrent assets:Cash and cash equivalents$

54,349,381$

70,599,146Marketable securities16,686,136—Accounts receivable, net of allowances6,017,2017,082,890Inventories6,218,3555,774,694Prepaid and other current assets1,671,0911,627,455Deferred tax assets2,290,0782,223,882Total current assets87,232,24287,308,067Property and equipment, net1,188,9141,119,339Intangible assets, net9,476,7987,023,064Deferred tax assets50,411—Other assets645,36667,846Total assets$

98,593,731$

95,518,316LIABILITIES AND EQUITYCurrent liabilities:Accounts payable$

2,790,554$

1,513,548Accrued liabilities5,264,8065,086,400Total current liabilities8,055,3606,599,948Revolving line of credit4,359,9514,859,951Deferred tax liability—645,029Other long-term liabilities611,933578,119Total liabilities13,027,24412,683,047Commitments and contingenciesEquity:Shareholders' equity:Common stock – no par value; 100,000,000 shares authorized;
8,937,107 and 20,020,535 shares issued and outstanding as of
December 31, 2012 and 2011, respectively67,197,16770,272,155Retained earnings18,499,15412,656,662Total shareholders' equity85,696,32182,928,817Noncontrolling interests(129,834)(93,548)Total equity85,566,48782,835,269Total liabilities and equity$

98,593,731$

95,518,316 

 CUMBERLAND PHARMACEUTICALS INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Income

(unaudited)Three months ended
December 31
'/>"/>

SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Cumberland Pharmaceuticals Reports First Quarter 2012 Financial Results
2. Cumberland Pharmaceuticals To Present At The 2012 Wells Fargo Securities Healthcare Conference In Boston
3. Cumberland Pharmaceuticals To Announce Second Quarter 2012 Financial Results On August 2, 2012
4. Cumberland Pharmaceuticals Reports Second Quarter 2012 Financial Results
5. Cumberland Pharmaceuticals to Present at the UBS Global Life Sciences Conference in New York
6. Cumberland Pharmaceuticals Reports Third Quarter 2012 Financial Results
7. Cumberland Emerging Technologies Expands Life Sciences Center
8. Cumberland Pharmaceuticals And PT. SOHO Industri Pharmasi enter Into Exclusive Licensing Agreement For Caldolor In Indonesia
9. Cumberland Pharmaceuticals To Announce 2012 Year End Financial Results On February 28, 2013
10. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
11. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... LONDON , July 11, 2014 /PRNewswire/ ... of visitors to Safety & Health Expo ... by the move to London ... senior management attending exhibition.     ... (Photo: http://photos.prnewswire.com/prnh/20140711/696892-a ) ...
(Date:7/10/2014)... , 11. Juli 2014 /PRNewswire/ ... Kameras für die molekulare Bildgebung, einschließlich ... heute die CE-Zulassung für sein Navigator ... kann Dilon das Produkt jetzt europaweit ... den Großteil der europäischen Länder ausgedehnt ...
(Date:7/10/2014)... , July 10, 2014 Integrated Silicon ... in advanced memory and analog IC solutions, today announced ... Thursday, July 24, 2014, at 7:00 a.m. Pacific Time ... results for the fiscal 2014 third quarter ended June ... via telephone, dial 1-888-556-4997 before 6:50 a.m. Pacific time ...
Breaking Medicine Technology:UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 2UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 3UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 4Dilon erhält CE-Zulassung für sein Navigator-Gamma-Sondensystem 2
(Date:7/11/2014)... London, UK (PRWEB) July 11, 2014 ... segment of the in-vitro diagnostics industry, which is expected ... next ten years. The sector owes its growth to ... threat to people’s health worldwide and a major factor ... diagnostic technologies, threat of bio-terrorism, and a broader availability ...
(Date:7/11/2014)... The report, “Specialty Synthetic Fibers & Glass ... 2018,” defines and segments the specialty synthetic fibers ... forecast of the volumes and values of types ... aramids, UHMW Polyethylene, carbon fiber, partially oxidized polyacrylonitrile ... PBO fiber, and liquid crystal polymer fiber and ...
(Date:7/11/2014)... GA (PRWEB) July 11, 2014 Datalogic ... step in improving sanitation hospital wide. With their new ... the spread of disease, like the devastating MRSA, which ... The Gryphon GD4400-HC 2D and the Gryphon ... 2D barcodes and can even read barcodes off of ...
(Date:7/11/2014)... July 11, 2014 Operators ... $50 billion in fuel costs now that ... current GHG standards are phasing ... it upon themselves to install new features ... 1.    Idle reduction technologies , 2.    Efficient driveline components ...
(Date:7/11/2014)... FRIDAY, July 11, 2014 (HealthDay News) -- Children ... greater risk for complications and potentially even death ... a new study. However, the Johns Hopkins ... "miniscule." The researchers analyzed data on nearly ... United States underwent over a 22-year period. ...
Breaking Medicine News(10 mins):Health News:World Virology and Bacteriology Testing Sector Discussed in Comprehensive VPG Research Report Published at MarketPublishers.com 2Health News:World Virology and Bacteriology Testing Sector Discussed in Comprehensive VPG Research Report Published at MarketPublishers.com 3Health News:Specialty Synthetic Fibers & Glass Fiber Market Poised to Reach $20.1 Billion at a CAGR of 5.2% by 2018 – Report by MarketsandMarkets 2Health News:Specialty Synthetic Fibers & Glass Fiber Market Poised to Reach $20.1 Billion at a CAGR of 5.2% by 2018 – Report by MarketsandMarkets 3Health News:Specialty Synthetic Fibers & Glass Fiber Market Poised to Reach $20.1 Billion at a CAGR of 5.2% by 2018 – Report by MarketsandMarkets 4Health News:Stop Spreading Disease with the New Disinfectant-Ready Bar Code Scanner 2Health News:Stop Spreading Disease with the New Disinfectant-Ready Bar Code Scanner 3Health News:LeaseQ Agrees the Latest Round of Greenhouse Gas Rules Could Increase the Cost of Truck Acquisition and Maintenance 2Health News:LeaseQ Agrees the Latest Round of Greenhouse Gas Rules Could Increase the Cost of Truck Acquisition and Maintenance 3Health News:Emergency Surgeries on Weekends Riskier for Kids: Study 2
... held belief, moderate levels of psychological stress in the ... to research conducted at the Johns Hopkins University and ... The study is published in the May/June 2006 edition ... that modest anxiety and daily stress during pregnancy is ...
... found out what it is that can induce maximum ... Their finding has revealed that toddlers learn the maximum ... they can associate with. ,The researchers conducted ... best-engaged toddlers. In the first, they tested differences in ...
... a genetic disorder which completely affects the immune system. ... gene //therapy was successfully used to cure this life ... School Of Veterinary Medicine and the National Institute of ... acts as a vector for the correct gene of ...
... of Pennsylvania and Temple University Plasminogen Activator Inhibitor Type ... the eye. This is a protein which is founding ... researchers, led by Mina Massaro-Giordano, M.D., of the University ... of the Sbarro Institute for Cancer Research at Temple ...
... in the May issue of Cancer Cell says that ... the mystery of how cancer progresses.// This molecule was ... cells both in vivo as well as in vitro. ... small molecule kinase inhibitors must display a broad reactivity ...
... the American Journal of Respiratory and Critical Care Medicine says ... loss in lung capacity equivalent to what usually happens after ... ,An average loss of 372 milliliters was noted, ... This loss is at least 10 times more than the ...
Cached Medicine News:Health News:Children Benefited By Moderate Maternal Stress? 2Health News:Interactive Video, Better Teaching Aid For Toddlers 2Health News:In-Vivo Gene Therapy Technique to Cure XSCID in Basset Pups 2Health News:In-Vivo Gene Therapy Technique to Cure XSCID in Basset Pups 3Health News:PAI-2 Plays a Pivotal Role in Eye Infections 2Health News:Discovery Of New Molecule Could Solve Cancer Spread Mystery 2
The Oscor PACE 101 H is an external single chamber cardiac demand pacemaker. The PACE 101 H feature an option for a atrial overdrive stimulation....
... pacing wire design offers reliable ... in the atrium and ventricle ... in one lead design. The ... ventricle are color-coded for easy ...
... proprietary quadripolar pacing wire design ... and sensing in the atrium ... bipolar wires in one lead ... atrium and ventricle are color-coded ...
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
Medicine Products: